Trump is reportedly considering easy some restrictions on cannabis, and investors are piling into the sector on Friday.

Florida and Texas have filed a lawsuit challenging more than two decades of federal government decisions that cleared the way for the use of abortion drugs — and said the availability of the drugs ...

Announcement, and lack of details in the weeks following, represents major departure from previous FDA priorities As the US’s top vaccine officials come under pressure from lawmakers and former ...

A Food and Drug Administration panel on Wednesday advocated for regulatory changes that would make testosterone medications more widely accessible, including removing their classification as ...

Dec 10 (Reuters) - Texas and Florida have launched the latest lawsuit seeking to restrict access to the abortion pill mifepristone, following the U.S. Food and Drug Administration's recent approval of ...

The US Food and Drug Administration is looking into whether deaths “across multiple age groups” have been related to Covid-19 vaccines, a spokesperson said Tuesday, weeks after a senior agency ...

Gillian Woollett, VP and head of regulatory strategy at Samsung Bioepis, discusses how the current regulatory climate is the result of years of work. Gillian Woollett: FDA’s approach to streamlining ...

The FDA is planning to tighten its regulations for vaccines, according to an internal email sent by Vinay Prasad, M.D., who heads up the agency’s Center for Biologics Evaluation and Research (CBER).

WASHINGTON — The American Civil Liberties Union (ACLU) filed a lawsuit yesterday to compel the Food and Drug Administration (FDA) to disclose records related to the agency’s review of its regulations ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Health secretary ...

Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. In April 2025, the U.S. Food and Drug Administration ...